These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1260651)

  • 1. Chemotherapy of malignant diffuse mesothelioma.
    Kucuksu N; Thomas W; Ezdinli EZ
    Cancer; 1976 Mar; 37(3):1265-74. PubMed ID: 1260651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of diffuse malignant mesothelioma. Phase II trials of single-agent 5-fluorouracil and adriamycin.
    Harvey VJ; Slevin ML; Ponder BA; Blackshaw AJ; Wrigley PF
    Cancer; 1984 Sep; 54(6):961-4. PubMed ID: 6467141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of adriamycin in the treatment of diffuse malignant pleural mesothelioma.
    Yap BS; Benjamin RS; Burgess MA; Bodey GP
    Cancer; 1978 Oct; 42(4):1692-6. PubMed ID: 709531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic approaches in malignant mesothelioma.
    Legha SS; Muggia FM
    Cancer Treat Rev; 1977 Mar; 4(1):13-23. PubMed ID: 66990
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study.
    Samson MK; Wasser LP; Borden EC; Wanebo HJ; Creech RH; Phillips M; Baker LH
    J Clin Oncol; 1987 Jan; 5(1):86-91. PubMed ID: 3543239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of pirarubicin (4'-0-tetrahydropyranyladriamycin) in malignant mesothelioma.
    Sridhar KS; Hussein AM; Feun LG; Zubrod CG
    Cancer; 1989 Mar; 63(6):1084-91. PubMed ID: 2917312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant mesotheliomas and chemotherapy.
    Karakousis CP; Seddiq M; Moore R
    J Surg Oncol; 1980; 15(2):181-5. PubMed ID: 7421277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of sarcomatoid malignant peritoneal mesothelioma responding to combination chemotherapy of cyclophosphamide, vincristine, adriamycin and dacarbazine(CYVADIC)].
    Kusama T; Kodaka T; Tsunemine H; Akasaka H; Koizumi N; Fujimoto K; Sakano S; Ito R; Kondo T; Kitazawa S; Yamamura H; Takahashi K
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):475-8. PubMed ID: 19295275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of doxorubicin versus cyclophosphamide in diffuse malignant pleural mesothelioma.
    Sørensen PG; Bach F; Bork E; Hansen HH
    Cancer Treat Rep; 1985 Dec; 69(12):1431-2. PubMed ID: 3907825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant pleural mesothelioma in a child: long-term survival with ICE-WAC chemotherapy regimen.
    Mutafoğlu-Uysal K; Kargi A; Sarialioğlu F; Olgun N; Kovanlikaya A
    Turk J Pediatr; 2002; 44(3):244-7. PubMed ID: 12405438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant mesothelioma presenting in the pleura and peritoneum.
    Mischler NE; Chuprevich T; Johnson RO; Tormey DC
    J Surg Oncol; 1979; 11(3):185-91. PubMed ID: 459514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant mesothelioma in children: report of seven cases and review of the literature.
    Brenner J; Sordillo PP; Magill GB
    Med Pediatr Oncol; 1981; 9(4):367-73. PubMed ID: 6790917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy with cisplatin and/or doxorubicin in malignant mesothelioma. A retrospective study [corrected from prospective].
    Tsavaris N; Primikirios N; Mylonakis N; Varouchakis G; Dosios T; Pavlidis N; Skarlos D; Tasopoulos T; Dritsas J; Kosmidis P
    Anticancer Res; 1997; 17(5B):3799-802. PubMed ID: 9427783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for malignant mesothelioma; CAMEO.
    Jett JR; Eagan RT
    Am J Clin Oncol; 1982 Aug; 5(4):429-31. PubMed ID: 7051806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer.
    De Lena M; Brambilla C; Morabito A; Bonadonna G
    Cancer; 1975 Apr; 35(4):1108-15. PubMed ID: 1116104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination modality therapy in lung cancer: a survival study showing beneficial results of AMCOF (adriamycin, methotrexate, cyclophosphamide, oncovin and 5-fluorouracil).
    Reynolds RD; O'Dell S
    Cancer; 1978 Aug; 42(2):385-9. PubMed ID: 209881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose methotrexate with citrovorum factor and vincristine in the treatment of malignant mesothelioma.
    Dimitrov NV; Egner J; Balcueva E; Suhrland LG
    Cancer; 1982 Oct; 50(7):1245-7. PubMed ID: 6980698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of malignant mesothelioma.
    Gerner RE; Moore GE
    Oncology; 1974; 30(2):152-5. PubMed ID: 4217436
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of six cases of mesothelioma with doxorubicin and cisplatin.
    Zidar BL; Pugh RP; Schiffer LM; Raju RN; Vaidya KA; Bloom RL; Horne D; Baker LH
    Cancer; 1983 Nov; 52(10):1788-91. PubMed ID: 6684983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase-II study with the combination of cisplatin and doxorubicin in advanced malignant mesothelioma of the pleura.
    Henss H; Fiebig HH; Schildge J; Arnold H; Hasse J
    Onkologie; 1988 Jun; 11(3):118-20. PubMed ID: 3045724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.